These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [Mechanism of action of diethylaminoethyl ether of diphenylpropylacetic acid (SKF-525A) on the neuromuscular synapse]. Magazanik LG Biull Eksp Biol Med; 1970 Mar; 69(3):10-4. PubMed ID: 5509101 [No Abstract] [Full Text] [Related]
49. Propranolol, a curariform and cholinomimetic agent at the frog neuromuscular junction. Werman R; Wislicki L Comp Gen Pharmacol; 1971 Mar; 2(5):69-81. PubMed ID: 4269641 [No Abstract] [Full Text] [Related]
50. Further studies on the neuromuscular effects of beta-diethylaminoethyl-diphenyl propylacetate hydrochloride (SKF-525-A). Suarez-Kurtz G; Paulo LG; Fonteles MC Arch Int Pharmacodyn Ther; 1969 Jan; 177(1):185-95. PubMed ID: 5353875 [No Abstract] [Full Text] [Related]
51. [Comparative study based upon the provoked potentials of various curare-like agents used in clinical practice]. Schlagdenhauffen J Anesth Analg (Paris); 1973; 30(5):929-34. PubMed ID: 4276288 [No Abstract] [Full Text] [Related]
52. In vivo reversal of depolarizing neuromuscular blockade. Riker WF; Okamoto M; Artusio JF Arch Int Pharmacodyn Ther; 1995; 330(1):90-101. PubMed ID: 8849313 [TBL] [Abstract][Full Text] [Related]
53. Mechanism of action of neostigmine at the neuromuscular junction. Webb SN J Pharm Pharmacol; 1971 Dec; 23():227S-228S. PubMed ID: 4401479 [No Abstract] [Full Text] [Related]
54. The interactions of neuromuscular blocking agents in man: the role of hexafluorenium. Torda TA; Foldes FF; Bailey RJ; Klonymus DH; Kuwabara S Anesthesiology; 1967; 28(6):1010-9. PubMed ID: 4383425 [No Abstract] [Full Text] [Related]
55. Experimental and clinical study of the effects of pancuronium bromide, a neuromuscular blocking agent. Manani G; Galzigna L; Mammano S; Gasparetto A Arzneimittelforschung; 1972 Sep; 22(9):1528-34. PubMed ID: 4264758 [No Abstract] [Full Text] [Related]
56. [The synergism of guanidine and the myorelaxant paramion at neuromuscular synapses]. Podlesnaia AI Biull Eksp Biol Med; 1968 May; 65(5):82-4. PubMed ID: 5757816 [No Abstract] [Full Text] [Related]
57. A comparison of the action of facilitatory and depolarizing drugs at the mammalian motor nerve terminal. Blaber LC; Goode JW Int J Neuropharmacol; 1968 Sep; 7(5):429-40. PubMed ID: 5731756 [No Abstract] [Full Text] [Related]
58. Muscle relaxants in small animal anesthesia. Lumb WV J Am Vet Med Assoc; 1972 Dec; 161(11):1436-41. PubMed ID: 4264297 [No Abstract] [Full Text] [Related]
59. The role of cholinesterase in the neuromuscular effects of succinylcholine, decamethonium and hexafluorenium. Scaf AH; van den Akker J; Westenberg HG Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):177-92. PubMed ID: 4846189 [No Abstract] [Full Text] [Related]
60. Effect of anesthetic drugs and muscle relaxants on intraocular pressure. Duncalf D; Foldes FF Int Ophthalmol Clin; 1973; 13(2):21-33. PubMed ID: 4274097 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]